Clearside Biomedical (CLSD) Stock Price
Clearside Biomedical Price
Over the last 8 years Clearside Biomedical grew revenue by 15.6% annually, reaching 1.66 M USD. For Clearside Biomedical, the net margin of -2,064.4% is down versus -230.8% a few years ago.
Clearside Biomedical stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Clearside Biomedical business model & stock analysis
Frequently asked questions about Clearside Biomedical
9 analysts currently rate the Clearside Biomedical stock: 0 recommend buying, 6 holding and 3 selling.
Converted at the current exchange rate, the Clearside Biomedical share trades at 0.37 EUR (0.41 USD).
The Clearside Biomedical share (CLSD) is listed on 4 stock exchanges, including: NASDAQ (CLSD), Frankfurt (CLM.F), München (CLM.MU), Düsseldorf (CLM.DU).
The revenue cannot currently be calculated for Clearside Biomedical.
The expected profit of Clearside Biomedical is -13.60 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Clearside Biomedical is currently -0.15. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Clearside Biomedical stock.
The P/S cannot be calculated for Clearside Biomedical currently.
The Eulerpool Quality Score for Clearside Biomedical is 5/10.
The ISIN of Clearside Biomedical is US1850632035. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Clearside Biomedical is A2ALP6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Clearside Biomedical is CLSD. The ticker symbol is used to trade Clearside Biomedical shares on the stock exchange.
Clearside Biomedical stock
Clearside Biomedical Peer Group
Clearside Biomedical Ticker
All fundamentals and in-depth analysis of Clearside Biomedical
Our stock analysis for Clearside Biomedical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearside Biomedical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.